Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cardiff Oncology Inc. | 3.660% | 4.362% | -38.593% | 106.786% | 145.441% | -53.857% | -7.714% |
| Ocular Therapeutix Inc. | 5.980% | 1.598% | -25.546% | -2.168% | 33.365% | -54.131% | 82.161% |
| Johnson & Johnson | -0.100% | 1.215% | 0.865% | -5.601% | -1.201% | -0.200% | 14.578% |
| Insmed Inc. | -0.850% | -2.500% | -10.000% | 36.842% | -18.182% | 8.333% | -8.504% |
| Chromadex Corp | 0.630% | -9.714% | -17.277% | 135.821% | 135.821% | -44.561% | - |
| MacroGenics Inc. | 1.230% | -72.485% | -75.103% | -37.758% | -54.356% | -82.840% | - |
| Cytomx Therapeutics Inc | -0.230% | -53.020% | -11.260% | 9.352% | 28.152% | -73.398% | - |
| Novavax Inc. | 2.270% | 190.213% | 208.479% | 59.364% | 178.253% | -88.547% | 91.462% |
| Coherus Bioscien. | -2.120% | -8.142% | -8.710% | -57.519% | -36.908% | -83.322% | -87.672% |
| Fibrogen Inc. | -3.990% | -13.672% | -10.717% | -93.196% | 27.384% | -93.837% | - |
| Fate Therapeutics Inc. | 5.480% | 6.663% | -29.219% | -16.205% | 8.043% | -93.911% | - |
| Edwards Lifesciences Corp. | 1.200% | 0.100% | -5.889% | -2.751% | 15.196% | 8.412% | 347.091% |